234
Participants
Start Date
October 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
July 31, 2016
NBI-98854
NBI-98854 40 mg capsules
Placebo
NBI-98854 placebo capsules
Little Rock
Anaheim
Glendale
Irvine
Long Beach
Los Angeles
National City
Norwalk
Oakland
Oceanside
San Bernardino
San Diego
Torrance
Bradenton
Hialeah
Kissimmee
Leesburg
Maitland
Miami
North Miami
Chicago
Oak Brook
Shreveport
Baltimore
Glen Burnie
Worcester
Flowood
St Louis
Lincoln
Amherst
Cedarhurst
Rochester
Durham
Pinehurst
Dayton
Shaker Heights
Oklahoma City
Conshohocken
Norristown
Phoenixville
Scranton
Charleston
Memphis
DeSoto
Fort Worth
Irving
Petersburg
Spokane
Vancouver
London
Toronto
Montreal
Caguas
San Juan
Lead Sponsor
Neurocrine Biosciences
INDUSTRY